My Fulbright project aims to understand the cellular changes that occur in bacteria upon treatment with antibiotic molecules developed in my lab. This will provide our team with insight into mechanisms of action and possible avenues for bacteria to develop resistance to our drugs.

Dr. Daniel Flaherty is the Chip and Jane Rutledge Early Career Associate Professor in Medicinal Chemistry and Molecular Pharmacology at Purdue University. His internationally recognised research focuses on developing inhibitors for drug-resistant bacterial pathogens.

As a Fulbright Scholar, Daniel will investigate bacterial protein expression changes in response to carbonic anhydrase inhibitors, furthering the development of effective treatments.

Home Institution Purdue University
Host Institution University of New South Wales
Award Name Fulbright Future Scholarship, Funded by the Kinghorn Foundation
Discipline Antibiotic Drug Discovery
Award Year 2025